Surgical approaches for stable vitiligo

Dermatologic Surgery

Volumn 31, Issue 10, 2005, Pages 1277-1284

  Falabella, Rafael ^a,b  

^a UNIVERSIDAD DEL VALLE   (Colombia)

^b CENTRO MÉDICO IMBANACO   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CLINICAL FEATURE; EPIDERMIS CELL; HUMAN; IN VITRO STUDY; MELANOCYTE; PATHOLOGICAL ANATOMY; PATIENT SELECTION; PIGMENT CELL; PRIORITY JOURNAL; PUVA; SURGICAL APPROACH; SURGICAL TECHNIQUE; TISSUE GRAFT; VITILIGO;

EID: 27744452467     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042728-200510000-00003     Document Type: Article

References (53)

1. Hann SK, Nordlund JJ. Clinical features of generalized vitiligo. In: Hann SK, Nordlund JJ, editors. Vitiligo. Oxford (UK): Blackwell Science; 2000. p. 35-48.
2. Porter J, Beuf A, Lerner A, Nordlund JJ. Response to cosmetic disfigurement: a study of patients with vitiligo. Cutis 1987;39:493-4.
3. Hann SK, Nordlund JJ. Definition of vitiligo. In: Hann SK, Nordlund JJ, editors. Vitiligo. Oxford (UK): Blackwell Science; 2000. p. 3-6.
4. Falabella R. Treatment of localized vitiligo by autologous minigrafting. Arch Dermatol 1988;124:1649-55.
5. Mulekar SV. Melanocyte-keratinocyte cell transplantation for stable vitiligo. Int J Dermatol 2003;42:132-6.
6. Gupta S, Kumar B. Epidermal grafting in vitiligo: influence of age, site of lesion, and type of disease on outcome. J Am Acad Dermatol 2003;49:99-104.
7. Boissy RE. The intrinsic (genetic) theory for the cause of vitiligo. In: Hann SK, Nordlund JJ, editors. Vitiligo. Oxford (UK): Blackwell Science; 2000. p. 123-8.
8. Bystryn JC. Theories on the pathogenesis of depigmentation. Immune hypothesis. In: Hann SK, Nordlund JJ, editors. Vitiligo. Oxford (UK): Blackwell Science; 2000. p. 129-36.
9. Hann SK, Chun WH. Autocytotoxic hypothesis for the destruction of melanocytes as the cause of vitiligo. In: Hann SK, Nordlund JJ, editors. Vitiligo. Oxford (UK): Blackwell Science; 2000. p. 137-41.
10. Orecchia GE. Neural pathogenesis. In: Hann SK, Nordlund JJ, editors. Vitiligo. Oxford (UK): Blackwell Science; 2000. p. 142-50.
11. Schallreuter KU, Beazley WD, Wood JM. Biochemical theory of vitiligo: a role of pteridines in pigmentation. In: Hann SK, Nordlund JJ, editors. Vitiligo. Oxford (UK): Blackwell Science; 2000. p. 151-9.
12. Njoo MD, Westerhof W. Vitiligo. Pathogenesis and treatment. Am J Clin Dermatol 2001;2:167-81.
13. Klisnick A, Schmidt J, Dupond JL, et al. Vitiligo in multiple autoimmune syndrome: a retrospective study of 11 cases and a review of the literature. Rev Med Intern 1998;19:348-52.
14. Tobin DJ, Swanson NN, Pittelkow MR, et al. Melanocytes are not absent in lesional skin of long duration vitiligo. J Pathol 2000;191:407-16.
15. Cui J, Shen LY, Wang GC. Role of hair follicles in the repigmentation of vitiligo. J Invest Dermatol 1991;97:410-6.
16. Grichnik JM, Ali WN, Burch JA, et al. KIT expression reveals a population of precursor melanocytes in human skin. J Invest Dermatol 1996;106:967-971.
17. Porter J, Beuf A, Lerner A, Nordlund JJ. Psychological reaction to chronic skin disorders: a study of patients with vitiligo. Gen Hosp Psychiatry 1979;1:73-7.
18. Falabella R. Surgical therapies for vitiligo. In: Hann SK, Nordlund JJ, editors. Vitiligo. Oxford (UK): Blackwell Science; 2000. p. 193-200.
19. Falabella R, Arrunategui A, Barona MI, Alzate A. The minigrafting test for vitiligo: detection of stable lesions for melanocyte transplantation. J Am Acad Dermatol 1995;32:228-32.
20. Olsson MJ, Juhlin L. Transplantation of melanocytes in vitiligo. Br J Dermatol 1995;132:587-91.
21. Falabella R, Escobar C, Borrero I. Treatment of refractory and stable vitiligo by transplantation of in vitro cultured epidermal autografts bearing melanocytes. J Am Acad Dermatol 1992;26:230-6.
22. Falabella R. Surgical techniques for repigmentation. In: Robinson SK, Arndt KA, LeBoit PE, Wintroub BU, editors. Atlas of cutaneous surgery. Philadelphia: W.B. Saunders; 1996. p. 175-84.
23. Falabella R. Grafting and transplantation of melanocytes for repigmenting vitiligo and leukoderma. Int J Dermatol 1989;28:363-9.
24. Falabella R. Surgical therapies for vitiligo. Clin Dermatol 1997;15:927-39.
25. Falabella R, Barona M, Escobar C, et al. Surgical combination therapy for vitiligo and piebaldism. Dermatol Surg 1995;21:852-7.
26. Skouge JW, Morison WL. Vitiligo treatment with a combination of PUVA therapy and epidermal autografts. Arch Dermatol 1995;131:1257-8.
27. Hann SK, Im S, Bong HW, Park YK. Treatment of stable vitiligo with autologous epidermal grafting and PUVA. J Am Acad Dermatol 1995;32:943-8.
28. Gauthier Y. Les techniques de greffe melanocytaire. Ann Dermatol Venereol 1995;122:627-31.
29. Olsson MJ, Juhlin L. Leucoderma treated by transplantation of a basal cell layer enriched suspension. Br J Dermatol 1998;138:644-8.
30. Kahn A, Cohen MJ. Vitiligo: treatment by dermabrasion and epithelial sheath grafting. J Am Acad Dermatol 1995;33:646-8.
31. McGovern TW, Bolognia J, Leffell DJ. Flip-top pigment transplantation: a novel transplantation procedure for the treatment of depigmentation. Arch Dermatol 1999;135:1305-7.
32. Falabella R. Repigmentation of leukoderma by autologous epidermal grafting. J Dermatol Surg Oncol 1984;10:136-44.
33. Kim HU, Yun SK. Suction device for epidermal grafting in vitiligo: employing a syringe and a manometer to provide an adequate negative pressure. Dermatol Surg 2000;26:702-4.
34. Gupta S, Shroff S, Gupta S. Modified technique of suction blistering for epidermal grafting in vitiligo. Int J Dermatol 1999;38:306-9.
35. Peachey RD. Skin temperature and blood flow in relation to the speed of suction blister formation. Br J Dermatol 1971;84:447-52.
36. van Geel N, Ongenae K, De Mil M, Naeyaert JM. Modified technique of autologous noncultured epidermal cell transplantation for repigmenting vitiligo: a pilot study. Dermatol Surg 2001;27:873-6.
37. 2 laser with a computerized pattern generator. Dermatol Surg 2001;27:565-8.
38. Falabella R. Surgical therapies for vitiligo and other leukodermas, part 1: minigrafting and suction epidermal grafting. Dermatol Ther 2001;14:7-14.
39. Albert S, Shenoi SD. Acetate sheets in the transfer of epidermal grafts in vitiligo. J Am Acad Dermatol 2001;44:719-20.
40. Falabella R, Escobar C, Borrero I. Transplantation of in vitro cultured epidermis bearing melanocytes for repigmenting vitiligo. J Am Acad Dermatol 1989;21:257-64.
41. Kaufmann R, Greiner D, Kippenberger S, Bernd A. Grafting of in vitro cultured melanocytes onto laser-ablated lesions in vitiligo. Acta Derm Venereol 1998;78:136-8.
42. Guerra L, Capurro S, Melchi F, et al. Treatment of "stable" vitiligo by timed surgery and transplantation of cultured epidermal autografts. Arch Dermatol 2000;136:1380-9.
43. Lontz W, Olsson MJ, Moellmann G, Lerner AB. Pigment cell transplantation for treatment of vitiligo: a progress report. J Am Acad Dermatol 1994;30:591-7.
44. Olsson MJ, Juhlin L. Transplantation of melanocytes in vitiligo. Br J Dermatol 1995;132:587-91.
45. Andreassi L, Pianigiani E, Andreassi A, et al. A new model of epidermal culture for the surgical treatment of vitiligo. Int J Dermatol 1998;37:595-8.
46. Olsson MJ, Moellman G, Lerner A, Juhlin L. Vitiligo repigmentation with cultured melanocytes after cryostorage. Acta Derm Venereol (Stockh) 1994;74:226-8.
47. Tomita Y, Maeda K, Tagami H. Melanocyte-stimulating properties of arachidonic acid metabolites: possible role in postinflammatory pigmentation. Pigment Cell Res 1992;5:357-61.
48. Tomita Y, Iwamoto M, Masuda T, Tagami H. Stimulatory effect of prostaglandin E2 on the configuration of normal human melanocytes in-vitro. J Invest Dermatol 1987;89:299-301.
49. Malakar S, Dhar S. Treatment of stable and recalcitrant vitiligo by autologous miniature punch grafting: a prospective study of 1,000 patients. Dermatology 1999;198:133-9.
50. Morelli JG, Kincannon J, Yohn JJ, et al. Leukotriene C4 and TGF-alpha are stimulators of human melanocyte migration in vitro. J Invest Dermatol 1992;98:290-5.
51. Horikawa T, Norris DA, Yohn JJ, et al. Melanocyte mitogens induce both melanocyte chemokinesis and chemotaxis. J Invest Dermatol 1995;104:256-9.
52. Falabella R. What's new in the treatment of vitiligo [editorial]. J Eur Acad Dermatol Venereol 2001;15:287-9.
53. Falabella R. Surgical treatment of vitiligo: why, when and how [editorial]. J Eur Acad Dermatol Venereol 2003;17:518-20.